subscribe: Posts | Comments

New cancer screening could spare women repeated smear tests

0 comments

Summary of story from The Telegraph, September 28, 2011

More than 100,000 women could be spared repeated smear tests every year by testing for the cancer causing strains of the human pappiloma virus (HPV) at the initial testing stage, according to a pilot study.

Currently, women who present mild abnormalities in cell structure during the initial smear test are asked to have the procedure again to check the results.

In some cases, this can result in up to three subsequent smear tests, which may be putting some women off.

The pilot study showed that around a third of women with low-grade cervical cell abnormalities who had multiple smear tests were sent home, as they did not carry the cancer-causing strains.

The other two-thirds were given fast tracked colposcopy examinations, which check for cancerous cells in the cervix, rather than repeated smear tests to monitor the initial results.

The study was based on more than 10,000 women, aged 25 to 64, whose initial smear test showed low-grade cellular abnormalities in the cervix.

They were taking part in a pilot programme at six “Sentinel Sites” – in Norwich, Bristol, Liverpool, Manchester, Sheffield and north west London – that started in 2007.

One of the authors of the report, Dr Sue Moss from the Institute for Cancer Research in Sutton, Surrey, said: “Our study shows that adding HPV testing significantly reduces the number of women sent for more invasive tests, when in fact they do not have any serious cervical changes.”

Director of the NHS Cancer Screening Programmes, Professor Julietta Patnick, said she and her colleagues were “very pleased” with the study’s results.

“The use of HPV testing that this paper reports is currently being incorporated into the screening programme nationwide and will be fully rolled out within the next year.

“By incorporating HPV testing into our current screening programme in this way, we will be able to significantly reduce the number of repeat cytology tests required and to target our colposcopy services more effectively.

“This is an important development in our programme enabling us to screen women more effectively and efficiently, reducing unnecessary procedures and minimising any associated anxiety” she said.

Leave a Reply

Your email address will not be published. Required fields are marked *